Purpose of this Study
We are doing this study to learn more about a medical technology called the ExoDx Prostate test. We want to find out if these test results can help us evaluate the risk of prostate cancer for patients and make better informed clinical decisions.
Who Can Participate?
Eligibility
Men ages 45+ who:<ul>
<li>Have low-intermediate risk prostate cancer</li>
<li>Are on active surveillance</li>
<li>Are scheduled for their second (confirmatory) biopsy</li></ul>
For more information, contact the study team at <a href= "mailto: shawna.pochan@duke.edu">shawna.pochan@duke.edu.</a>
<li>Have low-intermediate risk prostate cancer</li>
<li>Are on active surveillance</li>
<li>Are scheduled for their second (confirmatory) biopsy</li></ul>
For more information, contact the study team at <a href= "mailto: shawna.pochan@duke.edu">shawna.pochan@duke.edu.</a>
Age Range
45-110
Sex/Genders
Male (cisgender)
Non-binary or gender fluid
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you choose to join this study, we will ask you to provide a urine sample before you have your scheduled biopsy.
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
Evaluation of ExoDx Prostate in Men with Prostate Cancer in an Active
Surveillance Regimen- A Prospective Trial
Surveillance Regimen- A Prospective Trial
Principal Investigator
Judd
Moul
Protocol Number
PRO00111203
NCT ID
NCT05572099
Phase
N/A
Enrollment Status
Open to Enrollment